Program


 

Time

Track 1 (On-site Nijmegen)

Track 2 (On-line)

08:45 – 09:00

Opening and Welcome

09:00 – 09:30

Keynote 1: Dennis Schutter: Cerebellar neuromodulation in the treatment of depression and anxiety.

 

09:30 – 10:30

A - What can we learn from ECT: Insights from the GEMRIC consortium

Chairs: Indira Tendolkar & Philip van Eijndhoven

  1. Using electric field modeling to inform ECT dosing and device development, Zhi-De Deng
  2. Current connections: brain patterns in electroconvulsive therapy, Peter Mulders
  3. Global collaboration to study brain changes after ECT - current findings and future prospects, Leif Oltedal
  4. Efficacy of rTMS vs ECT for treatment resistant depression, Philip van Eijndhoven

B - New Methods in Non-Invasive Brain Stimulation 

Chairs: John Rothwell & Walter Paulus

  1. Updates on theta burst transcranial magnetic stimulation, Ying-Zu Huang
  2. Practicalities and Possibilities of Transcranial Ultrasound Stimulation, Lennart Verhagen
  3. Noninvasive Deep Brain Stimulation via Temporally Interfering Electric Fields: Nir Grossman
  4. New Applications for Transcranial Alternating Current Stimulation, Ivan Alekseichuk

10:30 – 10:45

Break

10:45 – 11:45

C - Transcranial Direct Current Stimulation and Psychological Interventions in Psychiatry: State of the Art and Promising Perspectives

Chair: Marie-Anne Vanderhasselt

 

  1. tDCS-augmented virtual reality exposure for PTSD: Possibility for Individualized Treatment, Mascha van ‘t Wout-Frank
  2. PsychotherapyPlus: Augmentation of Cognitive-Behavioral Therapy with Direct Current Stimulation, Malek Bajbouj
  3. Perspectives on Combined tDCS and Psychological Interventions, Josefien Dedoncker

 

 

11:45 – 12:45

D - Individualization and Personalization of NIBS.

Chairs: Noralie Krepel & Martijn Arns

  1. Concurrent TMS-EEG-fMRI to Visualize Brain-State Dependent iTBS Effects on Signal Propagation from the DLPFC, Alexander Sack
  2. Neurodevelopmentally Inspired EEG Biomarker for Treatment Stratification Across Various Antidepressant Interventions, Helena Voetterl
  3. Neuro-Cardiac-Guided TMS (NCG-TMS) to target the depression network: Possibilities for rTMS treatment stratification?, Martijn Arns

E - Non-Invasive Brain Stimulation in Multiple Sclerosis

Chair: Ulrich Palm

  1. Fatigue and Affective Manifestations in Multiple Sclerosis, Samar Ayache
  2. Cognitive Deficits in Multiple Sclerosis: Current knowledge and Perspectives  , Moussa A. Chalah
  3. tDCS and Fatigue in Multiple Sclerosis, Ulrich Palm
  4. tDCS and Cognitive Symptoms in Multiple Sclerosis, Christina Grigorescu

12:45 – 13:30

Lunch Break

13:30 – 14:00

Keynote 2: Antonio Mantovani: How to unlock OCD by non-invasive brain stimulation: from pathophysiology to clinical applications.

 

14:00 – 14:30

Keynote 3: Linda Carpenter: Insights and Inspirations from the first Decade of TMS Therapy in Psychiatry: A  TMS Clinician’s Perspective

 

14:30 – 15:30

F - Updated TMS Guidelines, Implications for Psychiatry

Chairs: André Aleman & Chris Baeken

  1. Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis, Marieke Begeman
  2. rTMS for depressive disorders: current knowledge and future directions. Chris Baeken
  3. NIBS for treatment of schizophrenia: hallucinations and negative symptoms, André Aleman

15:30 – 16:00

Break

 

KEYNOTE DEBATE: TO BIOTYPE OR NOT TO BIOTYPE?

16:00 – 16:30

Keynote 5: Jonathan Downar: Depression biotypes: how close are we to practical use in the clinic?

 

16:30 – 17:00

Keynote 6: André Marquand: Fractionating psychiatric cohorts using machine learning and big data

 

 

17:00 – 17:30

Keynote 7: Amit Etkin: Grounding Psychiatry in Scalable Brain-Based Biomarkers

 

17:30 – 18:00

DISCUSSION: HOW TO FOSTER A FUTURE OF ROBUST BIOMARKER STUDIES IN NIBS?

 

 

Closing Remarks and End

 

 

Keynote Speakers